Ionela Pascanu, MD, PhD

George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureş
Târgu Mureş, Romania

Disclosure information not submitted.

Presentation(s):

• ORF28-07 - A Phase II, Open-Label, Dose-Titration Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of the Novel Anti-ACTH Antibody Asedebart in Adults with Cushing's Disease

  Sunday, June 14, 2026
  2:45 PM - 3:00 PM CT